About Us Business Fields

Home
About Us
Business Fields

Healthcare

Business activities

Our Healthcare segment consists of Medical Systems, which includes medical IT and equipment, and LS Solutions, which includes the Bio CDMO^*1, Life Sciences, Pharmaceuticals, Consumer Healthcare and CRO^*2 businesses.
In the life sciences field, we have positioned CDMO and drug discovery support as priority businesses.

*1 Abbreviation for Contract Development & Manufacturing Organization, which offers services to pharmaceutical companies ranging from cell line development in the early stages of drug development, stability testing, and development and manufacturing of clinical trial drugs to commercial drug manufacturing.

*2 Abbreviation of Contract Research Organization, which provides services such as drug efficacy evaluation and safety testing, and support pharmaceutical research and development conducted by pharmaceutical companies, bio-ventures, academia, etc.

Market environment, social issues

Higher healthcare costs due to population aging
Grueling work environment due to healthcare worker shortages
The prevalence of many illnesses including the continued existence of cancer, new infectious diseases and other conditions for which no effective treatment methods have been established
Biopharmaceuticals have grown to account for around 30% of the global pharmaceutical market
The market for the CDMO business, which undertakes the development of production processes and manufacturing, is growing at an annual rate of about 10%

Through work in the fields of prevention, diagnosis and treatment,
Fujifilm is helping contribute to the creation of a healthy society by addressing social issues
such as unmet medical needs* and the necessity for improved access to medical services

* Medical needs for which no effective treatment methods have been established

Main products

Digital X-ray systems
Endoscope systems
CT and MRI systems
3D image analysis systems
Bio CDMO
Clinical diagnostic reagents
Culture mediums
Functional cosmetics

Competitive advantages

1.

Image processing and AI technologies for providing images suitable for diagnosis
2.

Advanced chemical compounds, design capabilities and nanotechnologies that enable development of pharmaceuticals to address unmet medical needs
3.

High levels of technological capabilities to manufacture under consistent conditions and with superior quality control utilized in the process development and manufacturing of biopharmaceuticals
4.

World-leading iPS cell initialization and differentiation induction technology and culture medium development capabilities

Growth strategies and future initiatives

Medical Systems

Medical IT is the core of this business, and through linkage with other product groups, we develop and provide a range of products and services to meet healthcare setting needs and contribute to the development of healthcare globally, and maintaining and improving the health of people around the world. In addition, we offer in-house-developed solutions to help eliminate disparities in healthcare, such as NURA, a health screening service business in India, and a portable X-ray imaging device for tuberculosis screening.
Life Sciences

In our Bio CDMO business, we make substantial capital investments primarily in industry-leading production technologies and antibody drugs to respond to rapidly growing demand for biopharmaceuticals. We are also expanding business under contract in a broad range of modalities, including the cutting-edge treatment field. In our Life Sciences business, we are speeding up global deployment, offering a wide lineup including culture mediums, iPS and other types of cells, reagents and cytokines, as well as wide-ranging proposal expertise.
Across the fields of prevention, diagnosis and treatment, Fujifilm provides the most advanced products and services on a global scale. As one of the world’s leading healthcare companies, we work to resolve healthcare challenges.

Medical Systems business strategies

Medical Systems business

Diverse equipment lineup and deepening of IT and AI technology to enhance our presence
―In addition to clinical value, create products and services that contribute to solving challenges in medical settings, such as providing workflow support
―Promote differentiation through solution proposals based on IT/AI and linkage with other equipment, rather than on stand-alone devices
Expansion of recurring business leveraging IT and AI technology
Expand existing business in health screening and expand NURA, a health screening center, to 100 locations worldwide

Strategies in the four businesses making up Life Sciences field

Bio CDMO business

Further expand our contract manufacturing business for gene and cell therapy drugs and other cutting-edge therapies
Achieve differentiation through industry-leading high-productivity technologies across modalities, including commercial continuous production systems allowing integrated production of antibody drugs, bispecific antibodies high-productivity cell line production
Establish one-stop service offerings including process development, drug substance manufacturing, fill/finish, assembly, labeling and packaging, from small-scale to large-scale production

Life Sciences business Drug discovery support, process development and contract manufacturing for cell therapy drug

In the drug discovery support field, sell iPS and other cells, culture mediums and reagents as a package on the global market
In the cell therapy drug field utilizing iPS cell technology and knowhow, accelerate the development of therapy products with tie-up partners and advance the development and contract manufacturing business
For culture mediums, improve supply capabilities and customer support in production systems focused on three zones: the U.S., Europe and Japan

Pharmaceuticals business

Promote liposomal formulation development using our nano-dispersion, analysis and process technologies
Use our lipid nanoparticulate manufacturing facilities and infrastructure to build a process development and contract manufacturing business for next-generation nucleic acid drugs and mRNA vaccines

Consumer Healthcare business Cosmetics and supplements

Apply liposome technology to cosmetics to launch highly distinctive, functional cosmetics and boost brand value
Utilizing technology developed over the years, launch new brands appealing to a broad range of age groups and needs
In the supplements field, respond to growing needs to maintain and improve health

Electronics * Formerly known as Materials, this segment name has been changed to Electronics.

Business activities

We provide advanced materials for communication devices, sensors and next-generation displays that support people’s lives in the age of AI and IoT. The Electronics segment consists of the Semiconductors Materials business and the Advanced Functional Materials Division (AF Materials Division: Display Materials, Industrial Products and FIne Chemicals).

Market environment, social issues

Growing demand for semiconductors due to the spread of 5G and autonomous driving and the speeding up of digital transformation
Development of materials for high-performance semiconductors and more resilient supply chains to ensure stable supply
More uses for functional materials for displays in vehicles, etc.

By developing and providing cutting-edge functional materials,
Fujifilm contributes to creating a safe and secure society
in the age of digital transformation

Main products

Photoresists for electronic materials
Color filters for image sensors
Infrared related materials for sensing applications
CMP slurry
Sensor film for touch panel
Protective film for polarizer
LTO tape
FIne Chemicals

Competitive advantages

1.

Advanced technologies, such as functional molecular technology for impacting high functionality to film
2.

Advanced film forming and coating technologies to support advances in thinness and display size
3.

Cost competitiveness and stable supply
4.

Rapid and accurate product formulation capabilities and development capabilities, and a global production and supply system

Growth strategies and future initiatives

Combining optical wavelength control and other technologies developed in each business, we will continue creating new businesses to help speed up digital transformation in different fields by setting up 5G and other high-speed communication networks and developing high-performance sensors and communication devices. We will maintain our current competitive advantage to boost sales and profits by rapidly introducing profitable products meeting market needs.

Strategies in the two businesses making up Electronics segment

Semiconductor Materials business

In addition to business expansion through one-stop solutions, acquire business in advanced EUV based on our strengths in CMP slurry and NTI development, which has a high market share, and propose new materials for Beyond EUV
Strengthen the supply chain network for major customers who are expanding globally
Respond to geopolitical risks and launch and expand businesses in emerging markets
Develop high-value-added products and businesses utilizing a broad portfolio and technologies

AF Materials business

Promote businesses targeting growth markets such as anti-reflective materials for OLEDs which is expanding in the smartphone and IT fields; touch sensor materials; and luminescent layer materials
Increase our presence in the industry by proposing multiple new materials to manufacture for micro-OLED, AR/VR and mobility, which are expected to be the next-generation HMI, supporting them in addressing key challenges
Based on the technologies of the Electronics Materials Group, propose and implement new materials that capture customer needs by utilizing the customer contacts in the communications market and the energy market that have been accumulated to date

Imaging

Business activities

The Imaging segment consists of two businesses: Consumer Imaging and Professional Imaging. In the Consumer Imaging business, we offer everything from color film and instant photo systems (instax) to printing equipment, color paper and photo printing services. In the Professional Imaging business, we offer high-end mirrorless digital cameras (such as the GFX series, which delivers the ultimate in image quality and the compact, lightweight, high image quality X series), broadcast and cinema lenses, long-range surveillance camera and machine vision lenses, projectors and digital signage.

Market environment, social issues

Demand for events and travel has recovered, and demand for print businesses such as instant photo systems and digital cameras is growing steadily. In addition, business opportunities are expanding due to the growth in demand for lenses resulting from the shift to Iot and 4K/8K video, as well as the growth of the surveillance camera market in response to social issues such as increasing disasters and aging infrastructure.

Fujifilm helps strengthen people-to-people relationships
and enrich lives through photos and images

Main products

Instax™
Apps for instax™
QuickSnap
Photo books
X Series mirrorless digital camera
GFX Series mirrorless digital camera
Lenses for 8K broadcasting
Ultra-short throw commercial projectors

Competitive advantages

1.

Planning capabilities capable of anticipating user needs and technological development capabilities allowing sustained creation of distinctive products
2.

Advanced technologies supporting unique products (photosensitive materials, optics, image design, precision processing and assembly)
3.

Comprehensive capabilities to provide services from input (shooting) to output (printing)
4.

Strong market position as a leading company (global brand power and marketing and sales capabilities)

Growth strategies and future initiatives

Expand the Imaging business by launching interesting new instant photo systems and mirrorless digital cameras, invigorating demand for photo printing through campaigns communicating the value of photo printing, and advancing into new BtoB areas such as projectors and surveillance cameras. In the film and photo contents business and the film/image processing solutions business, accelerate creation of new products and services.

Strategies in the two fields making up Imaging segment

Consumer Imaging

Expand the user customer base by continuously launching attractive and unique products that combine analog taste with digital technology
Increase loyal customers by marketing DX and enforcing direct user communication

Professional Imaging

Strengthen the two-line strategy of the "X Series," with the best balance of compact, lightweight, and high image quality, and the "GFX Series" with the highest image quality equipped with large format
Create new businesses and solve social issues by combining technological assets, unique devices and expertise in imaging

Business Innovation

Business activities

The Business Innovation segment consists of the Business Solutions business, which helps customers address their business challenges through DX and work-style Innovation by providing system integration and cloud services tailored to the characteristics of each industry and business; multifunction device management solutions, along with BPO^*3 and ITO^*4 for core business processes; the Office Solutions business, which provides office equipment and supplies such as multifunction devices and printers; and the Graphic Communications business, which provides offset printing equipment, digital printing systems and inkjet-related products.

*3 Business Process Outsourcing

*4 IT Outsourcing

Main products

Multifunction printers
Production printers
CocoDesk private office service
DocuWorks

See here for details

FUJIFILM Business Innovation Corp.